Counting costs. Patients will suffer from limits on Alzheimer's drugs.
Nurs Stand. 2005 May 25-31;19(37):24-5.
Please login to recommend the paper.
Make a Comment
This is sobering news from a national health service that makes tough choices on balancing costs for AD medications with data on their long-term as well as short-term efficacy.
To make a comment you must login or register.